Flow Traders U.S. LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Flow Traders U.S. LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 11,886 shares of the company’s stock, valued at approximately $839,000. Flow Traders U.S. LLC owned 0.12% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. McElhenny Sheffield Capital Management LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the second quarter worth about $18,942,000. Aptus Capital Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at about $12,165,000. Rockport Wealth LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at about $12,091,000. Southern Capital Advisors LLC increased its position in shares of iShares U.S. Pharmaceuticals ETF by 1.1% during the third quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock valued at $2,844,000 after acquiring an additional 448 shares during the last quarter. Finally, Commonwealth Equity Services LLC increased its position in shares of iShares U.S. Pharmaceuticals ETF by 7.3% during the second quarter. Commonwealth Equity Services LLC now owns 38,172 shares of the company’s stock valued at $2,532,000 after acquiring an additional 2,589 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE opened at $68.93 on Wednesday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $58.85 and a 1-year high of $72.94. The stock has a market cap of $696.19 million, a PE ratio of 6.49 and a beta of 0.58. The firm has a 50-day simple moving average of $69.65 and a two-hundred day simple moving average of $68.93.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.